Jun 16, 2026 07:02AM
Jun 12, 2026 05:16AM
May 14, 2026 06:44AM
May 14, 2026 04:48AM
May 13, 2026 07:18AM
May 6, 2026 04:21AM
Apr 29, 2026 06:58AM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)
Apr 6, 2026 02:07AM
Mar 25, 2026 06:55AM
Mar 23, 2026 03:50PM
Mar 23, 2026 02:01PM
Mar 23, 2026 12:40PM
Feb 24, 2026 09:14AM
Feb 2, 2026 06:09AM Guggenheim Starts Avalo Therapeutics Inc. (AVTX) at Buy
Jan 15, 2026 06:45AM
Dec 22, 2025 07:06AM
Dec 17, 2025 04:03PM
Oct 1, 2025 07:00AM
Sep 18, 2025 06:58AM
Sep 18, 2025 06:13AM
Sep 5, 2025 05:29AM TD Cowen Starts Avalo Therapeutics Inc. (AVTX) at Buy
Aug 15, 2025 06:10AM
Aug 7, 2025 09:33AM
Jul 22, 2025 08:34AM
Jun 30, 2025 01:43PM
Jun 18, 2025 07:01AM
Jun 2, 2025 06:37AM
May 13, 2025 06:27AM Avalo Therapuetics (AVTX) Misses Q1 EPS by 125c
Mar 26, 2025 07:02AM
Mar 25, 2025 12:24AM
Mar 24, 2025 04:07PM
Mar 24, 2025 06:32AM
Feb 28, 2025 06:28AM
Jan 2, 2025 07:02AM
Dec 19, 2024 06:05AM BTIG Starts Avalo Therapeutics Inc. (AVTX) at Buy
Nov 12, 2024 07:06AM
Oct 8, 2024 12:29PM
Oct 8, 2024 07:01AM
Aug 15, 2024 06:38AM
Aug 12, 2024 07:59AM
Jul 16, 2024 07:01AM
Jul 9, 2024 07:02AM Avalo Therapuetics (AVTX) Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
Jun 24, 2024 04:02PM

404,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All